Envoy Medical, Inc.
COCH
$1.48
$0.021.37%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 42.00K | 56.00K | 68.00K | 59.00K | 95.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 42.00K | 56.00K | 68.00K | 59.00K | 95.00K |
| Cost of Revenue | 157.00K | 187.00K | 245.00K | 153.00K | 234.00K |
| Gross Profit | -115.00K | -131.00K | -177.00K | -94.00K | -139.00K |
| SG&A Expenses | 1.94M | 2.09M | 2.09M | 2.44M | 3.53M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.57M | 5.03M | 4.93M | 4.96M | 6.82M |
| Operating Income | -4.52M | -4.97M | -4.86M | -4.90M | -6.72M |
| Income Before Tax | -4.62M | -5.96M | -3.95M | -6.27M | -4.90M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.62M | -5.96M | -3.95M | -6.27M | -4.90M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.62M | -5.96M | -3.95M | -6.27M | -4.90M |
| EBIT | -4.52M | -4.97M | -4.86M | -4.90M | -6.72M |
| EBITDA | -4.48M | -4.93M | -4.82M | -4.86M | -6.68M |
| EPS Basic | -0.47 | -0.37 | -0.27 | -0.39 | -0.33 |
| Normalized Basic EPS | -0.18 | -0.19 | -0.13 | -0.20 | -0.16 |
| EPS Diluted | -0.48 | -0.37 | -0.27 | -0.39 | -0.34 |
| Normalized Diluted EPS | -0.18 | -0.19 | -0.13 | -0.20 | -0.16 |
| Average Basic Shares Outstanding | 16.35M | 19.62M | 19.60M | 19.60M | 18.72M |
| Average Diluted Shares Outstanding | 16.35M | 19.62M | 19.60M | 19.60M | 18.72M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -13.30% | -30.76% | -- | -- | -- |